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Dear Editor, We read with great interest the article published in September 2019 by Ozen et al. (1) entitled ‘European 
consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis – the SHARE initiative’. 
Firstly, we would like to congratulate all members of the Single Hub and Access point for paediatric rheumatology in 
Europe (SHARE) initiative for developing such important recommendations for childhood IgA vasculitis (IgAV) as this is 
a disease that significantly lacks an evidence base to guide best practice. The recommendations were formulated as a 
result of a systematic literature review and a process of agreement among an expert group of European 
rheumatologists with a representative nephrologist and we acknowledge the extensive effort that this must have 
taken.  
We are writing to inform you that a group of 10 nephrologists (9 paediatric, 1 adult) with an interest in IgAV nephritis 
(Henoch Schonlein purpura nephritis) met on 17th October, 2019 in Venice, Italy for an international workshop. The 
aim of the workshop was to discuss a much needed clinical trial for children with biopsy proven IgAV nephritis. As part 
of this workshop, we incorporated a session focused on when to perform a renal biopsy in these children and we are 
delighted to report that the SHARE recommendations were met with great enthusiasm.  Generally, the attendees, who 
represented 9 different nephrology institutions from across the world, supported the recommendations however we 
did note areas that would benefit from clarification to improve their interpretation. This is particularly important as 
the renal monitoring for this disease is predominantly delivered by non-specialists. As a group we felt that changes in 
renal function would be better based on changes in creatinine values rather than the more complex estimated 
glomerular filtration rate to ease interpretation; this would be aligned with recent international efforts to standardise 
the definition of acute kidney injury (2, 3).  Additionally, we felt that due to the increased risk of significant long term 
renal consequences in children with nephrotic and/or nephritic syndrome (e.g. up to 19.5%) (4-6), as is stated in the 
manuscript, it would be important to specifically state that the presence of nephrotic syndrome should also be an 
absolute indication to performing a renal biopsy. Finally the group acknowledged the importance of providing 
equivalent proteinuria thresholds if these recommendations are to become adopted into international clinical 
guidelines as reporting of creatinine or proteinuria concentrations vary in different countries. .  We have therefore 
combined the SHARE recommendations with the suggested terminology improvements from our international 
workshop into a user friendly table (Table 1). 
The next phase would be to receive input from our general paediatric colleagues on the suitability of these indications 
as we move towards incorporating them into management recommendations.  Once again we would like to 
congratulate the SHARE expert group, as they have started the process of standardising an important aspect of 
management in childhood IgAV, as we work together to achieve the vision that no child with IgAV should get chronic 
kidney disease. 
Table 1: Suggested absolute and relative indications for performing a renal biopsy in IgA vasculitis (adapted using (1, 
2))
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